Purchase Order FA500023P0082
- Not listed
- This is a $480,451.02 Firm Fixed Price definitive contract awarded by the Department of Veterans Affairs to Roche Diagnostics Corporation for benchmark maintenance services. The contract has an ultimate completion date of April 30, 2023 and was not set aside for any special program. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract provides critical care analyzers, reagents, test kits,...
- This is a firm fixed-price BPA call order awarded by the Defense Health Agency to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for $1,602,293.52 worth of 6 months of supplies to be drop-shipped. The award has a completion date of September 28, 2024 and is not set aside. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. They have received numerous prime and subcontract...
- This is a federal contract award to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $947,520.62, was awarded by the Medical Command within the U.S. Department of Defense on October 1, 2020 for a period ending on September 30, 2021. The contract is a Delivery Order under a Firm Fixed Price pricing type and does not have a set-aside designation....
- This is a firm fixed-price purchase order awarded by the Air Mobility Command to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for preventative maintenance on a VENTANA BENCHMARK ULTRA SLIDE STAINER. The total ceiling value of the contract is $93,895.92, with a period of performance through June 12, 2022. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services, and has...
- This is a firm-fixed-price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The contract, valued at $108,800.00, is for preventative maintenance services to be performed by March 31, 2028. Roche Diagnostics has previously received awards from various federal agencies, including the Department of...
- This is a $787,038.78 firm fixed-price delivery order contract awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and medical products. The contract, which has no set-aside designation, provides for the delivery of Roche's medical diagnostic technologies, including laboratory equipment, testing systems, reagents, and clinical testing services, to support...
- This is a delivery order contract awarded by the Defense Health Agency (DHA), a defense agency, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and associated products and services. The $341,575.26 firm-fixed-price contract provides reagents under the Critical Analyzers, Laboratory GSA Schedule contract (FSS-66-III). The contract has an ultimate completion date of March 31, 2025. Roche Diagnostics has a history of providing medical equipment,...
- This firm fixed-price purchase order was awarded by the Defense Health Agency to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, with a potential value of $230,895.88, is for the provision of immunoassay services on a per-reportable-result basis, with a completion date of April 30, 2022. Roche Diagnostics has a history of providing critical care analyzers,...
- This is a $86,944 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for a ROCHE SERVICE AGREEMENT with a period of performance through September 2024. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies,...
- This is a firm fixed-price purchase order contract awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Roche Diagnostics Corporation for the maintenance of a BENCHMARK XT N750 model. The contract has a ceiling value of $19,637.33 and a period of performance ending on September 30, 2017. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract...
This is a $89,826.20 firm fixed-price purchase order awarded by the Defense Health Agency to Roche Diagnostics Corporation for benchmark ultra service and maintenance in accordance with the attached performance work statement and pricing schedule. The contract has a period of performance through September 30, 2028 and was awarded on October 1, 2023. This award is not a set-aside contract. Roche Diagnostics is a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services, with a focus on providing critical healthcare technologies and laboratory solutions to federal agencies including the Department of Veterans Affairs, Department of Defense, and Department of Health and Human Services. The contract is likely being issued under Roche's existing General Services Administration Federal Supply Schedule contracts for critical analyzers and in vitro diagnostics.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Funding Only Action | $18.0k | 10/7/24 | |
| P00002 | Exercise an Option | $0 | 9/19/24 | |
| P00001 | Funding Only Action | $18.0k | 10/1/23 | |
| Not listed | Not listed | $0 | 9/29/23 |